These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29299820)

  • 21. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
    Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
    J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of pituitary neoplasms with temozolomide: a review.
    Syro LV; Ortiz LD; Scheithauer BW; Lloyd R; Lau Q; Gonzalez R; Uribe H; Cusimano M; Kovacs K; Horvath E
    Cancer; 2011 Feb; 117(3):454-62. PubMed ID: 20845485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk pituitary adenomas and strategies for predicting response to treatment.
    Kontogeorgos G; Thodou E; Osamura RY; Lloyd RV
    Hormones (Athens); 2022 Mar; 21(1):1-14. PubMed ID: 35061210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
    Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
    Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of invasive silent somatotroph pituitary adenoma with temozolomide. Report of a case and review of the literature.
    Ghazi AA; Rotondo F; Kovacs K; Amirbaigloo A; Syro LV; Fathalla H; Di Ieva A; Cusimano MD
    Endocr Pathol; 2015 May; 26(2):135-9. PubMed ID: 25716461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.
    Gabalec F; Beranek M; Netuka D; Masopust V; Nahlovsky J; Cesak T; Marek J; Cap J
    Pituitary; 2012 Jun; 15(2):222-6. PubMed ID: 21597974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
    Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
    Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a role for early chemotherapy in the management of pituitary adenomas?
    Lin AL; Sum MW; DeAngelis LM
    Neuro Oncol; 2016 Oct; 18(10):1350-6. PubMed ID: 27106409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.
    McCormack AI; Wass JA; Grossman AB
    Eur J Clin Invest; 2011 Oct; 41(10):1133-48. PubMed ID: 21496012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical, invasive, recurring Crooke cell adenoma of the pituitary.
    Rotondo F; Cusimano M; Scheithauer BW; Coire C; Horvath E; Kovacs K
    Hormones (Athens); 2012; 11(1):94-100. PubMed ID: 22450349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
    Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M
    Eur J Endocrinol; 2010 Dec; 163(6):843-51. PubMed ID: 20870708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the 2017 WHO Classification of Pituitary Tumors.
    Mete O; Lopes MB
    Endocr Pathol; 2017 Sep; 28(3):228-243. PubMed ID: 28766057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refractory pituitary adenoma: a novel classification for pituitary tumors.
    Dai C; Feng M; Liu X; Ma S; Sun B; Bao X; Yao Y; Deng K; Wang Y; Xing B; Lian W; Zhong D; Ma W; Wang R
    Oncotarget; 2016 Dec; 7(50):83657-83668. PubMed ID: 27845901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series.
    Padovan M; Cerretti G; Caccese M; Barbot M; Bergo E; Occhi G; Scaroni C; Lombardi G; Ceccato F
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):181-198. PubMed ID: 36876325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
    Ferone D; Lastoria S; Colao A; Varrella P; Cerbone G; Acampa W; Merola B; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):248-52. PubMed ID: 9435450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinically non-functioning human pituitary adenomas.
    Asa SL; Kovacs K
    Can J Neurol Sci; 1992 May; 19(2):228-35. PubMed ID: 1623451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinico-pathologic study of pituitary adenomas.
    Sarkar C; Roy S; Kochupillai N; Gupta N; Tandon PN
    Indian J Med Res; 1990 Oct; 92():315-23. PubMed ID: 2272669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of temozolomide in aggressive pituitary tumors: case report.
    Mohammed S; Kovacs K; Mason W; Smyth H; Cusimano MD
    Neurosurgery; 2009 Apr; 64(4):E773-4; discussion E774. PubMed ID: 19349807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients.
    Burman P; Trouillas J; Losa M; McCormack A; Petersenn S; Popovic V; Theodoropoulou M; Raverot G; Dekkers OM;
    Eur J Endocrinol; 2022 Oct; 187(4):593-605. PubMed ID: 36018781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center.
    Ceccato F; Lombardi G; Manara R; Emanuelli E; Denaro L; Milanese L; Gardiman MP; Bertorelle R; Scanarini M; D'Avella D; Occhi G; Boscaro M; Zagonel V; Scaroni C
    J Neurooncol; 2015 Mar; 122(1):189-96. PubMed ID: 25555563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.